Incidence, severity, and etiology of drug-induced acute pancreatitis

Digestive Diseases and Sciences

Volumn 55, Issue 10, 2010, Pages 2977-2981

  Vinklerová, Ilona ^a   Procházka, Michal ^a   Procházka, Vlastimil ^a   Urbánek, Karel ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b NONE

Author keywords

Acute pancreatitis; Adverse drug reactions; Azathioprine; Crohn's disease; Drug induced pancreatitis; Retrospective study

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYTARABINE; DEXAMETHASONE; MESALAZINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAMIPRIL; VALPROIC ACID; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BILIARY TRACT DISEASE; CHILD; DISEASE SEVERITY; DRUG INDUCED DISEASE; DYSLIPIDEMIA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS DIVISUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; RETROSPECTIVE STUDY; SCHOOL CHILD; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; CROHN DISEASE; HOSPITALIZATION; INCIDENCE; MIDDLE AGED; PANCREATITIS; RISK FACTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; CYTARABINE; DEXAMETHASONE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MESALAMINE; MIDDLE AGED; MYCOPHENOLIC ACID; PANCREATITIS; RAMIPRIL; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VALPROIC ACID; YOUNG ADULT;

EID: 77957913897     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1277-3     Document Type: Article

References (19)

1. McArthur KE. Review article: drug-induced pancreatitis. Aliment Pharmacol Ther. 1996;10(1):23-38.
2. Mallory A, Kern F Jr. Drug-induced pancreatitis: a critical review. Gastroenterology. 1980;78:813-820.
3. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39(8):709-716.
4. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648-661.
5. Banks PA, Freeman ML, The Practice Parameter Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101:2379-2400.
6. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-1259.
7. Mennecier D, Pons F, Arvers P, et al. Incidence and severity of non alcoholic and non biliary pancreatitis in a gastroenterology department. Gastroenterol Clin Biol. 2007;31(8-9 Pt 1):664-667.
8. Balani AR, Grendell JH. Drug-induced pancreatitis. Incidence, management and prevention. Drug Safety. 2008;31(10):823-837.
9. Lankisch PG, Droge M, Gottesleben F. Drug-induced acute pancreatitis: incidence and severity. Gut. 1995;37:565-567.
10. Gullo L, Migliori M, Oláh A, et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas. 2002; 24(3):223-227.
11. Massironi S, Losco A, Basilisco G. Drug side-effects in IBD. Aliment Pharmacol Ther. 2002;16(10):1831.
12. Moolsintong P, Loftus EV Jr, Chari ST, et al. Acute pancreatitis in patients with Crohn's disease: clinical features and outcomes. Inflamm Bowel Dis. 2005;11(12):1080-1084.
13. Barthet M, Lesavre N, Desplats S, et al. Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease. Pancreatology. 2006;6(5):464-471.
14. Bermejo F, Lopez-Sanroman A, Taxonera C, et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther. 2008;28(5):623-628.
15. Weersma RK, Peters FT, Oostenbrug LE, et al. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. Aliment Pharmacol Ther. 2004; 20(8):843-850.
16. Bajaj JS, Saeian K, Varma RR, et al. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience. Am J Gastroenterol. 2005;100(5):1121-1125.
17. Ransford RA, Langman MJ. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002;51(4):536-539.
18. Kanbay M, Korkmaz M, Yilmaz U, et al. Acute pancreatitis due to ramipril therapy. Postgrad Med J. 2004;80:617-618.
19. Anagnostopoulos GK, Kostopoulos P, Tsiakos S, et al. Fulminant pancreatitis associated with ramipril therapy. Pancreas. 2003; 27:278-279.